Search results
Results from the WOW.Com Content Network
Diphenhydramine, sold under the brand name Benadryl among others, is an antihistamine and sedative. It is a first-generation H 1 -antihistamine and it works by blocking certain effects of histamine , which produces its antihistamine and sedative effects.
Benadryl can also be found in a topical form including gels and creams. Benadryl Itch Stopping Cream is a topical cream used to provide temporary itch relief for allergies, hives or even some insect bites. It can be found in the United States and Canada. This topical medication contains 2% of diphenhydramine hydrochloride and 1% of zinc acetate.
Calpol is a brand of children's medicine sold in the UK, Ireland, India, Cyprus, Hong Kong, Kenya, Malta, Philippines and Turkey.The main product is a paracetamol suspension, branded as Calpol Infant Suspension.
Vicks NyQuil is a brand of over-the-counter medication manufactured by Procter & Gamble intended for the relief of various symptoms of the common cold; the spokesman is Michael Daingerfield of CBS, Global and Nickelodeon fame.
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, [3] Kenvue is the proprietor of well-known brands such as Aveeno, [4] Band-Aid, [5] Benadryl, Combantrin, Zyrtec, [6] Johnson's, [7] Listerine, [8] Mylanta, Neutrogena, [4] Trosyd, Calpol, Tylenol, [8] and Visine.
In order to come up with a list of promising investment targets, I established a cut-off line of $5 billion in market cap. That limits the choice to just 30 different cryptocurrencies.
In July 1975, the J. B. Williams Co. began marketing Sominex 2. [37] On November 24, 1975, Attorney General Evelle J. Younger filed suit on behalf of the State of California against Williams Co., stating that the product did not warn against use by pregnant or nursing women or persons with asthma or COPD, nor did it notify consumers that it should not be used in conjunction with alcohol. [38]
(Reuters) -Elon Musk's SpaceX is preparing to launch a tender offer in December to sell existing shares at a price of $135 per share, two sources familiar with the matter said. The tender offer ...